Beryl Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE415H01017
  • NSEID:
  • BSEID: 524606
INR
24.08
0.04 (0.17%)
BSENSE

Aug 10

BSE+NSE Vol: 861

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 302214,
    "name": "Beryl Drugs",
    "stock_name": "Beryl Drugs",
    "full_name": "Beryl Drugs Ltd",
    "name_url": "stocks-analysis/beryl-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "24.08",
    "chg": 0.04,
    "chgp": "0.17%",
    "dir": 1,
    "prev_price": "24.04",
    "mcapval": "12.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524606,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE415H01017",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "861 ",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/beryl-drugs-302214-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 5,
    "sid": "302214",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/beryl-drugs-302214"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2026",
      "datetime": "05-Aug-2026",
      "details": "Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Temporary Unavailability Of The Companys Website Due To An Unexpected Technical Issue",
      "datetime": "21-Jul-2026",
      "details": "TEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE www.beryldrugs.com DUE TO AN UNEXPECTED TECHNICAL ISSUE.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jul-2026",
      "details": "CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2026

05-Aug-2026 | Source : BSE

Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026

Intimation Regarding Temporary Unavailability Of The Companys Website Due To An Unexpected Technical Issue

21-Jul-2026 | Source : BSE

TEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE www.beryldrugs.com DUE TO AN UNEXPECTED TECHNICAL ISSUE.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Jul-2026 | Source : BSE

CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(11 Aug 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available